John Q. Trojanowski, MD,Tufts University, PhD, Tufts University 1976

Affiliations: 
Pathology and Laboratory Medicine University of Pennsylvania, Philadelphia, PA, United States 
Area:
Neurodegenerative diseases
Website:
http://pathology.uphs.upenn.edu/Faculty/FacultyInfo.aspx?site=FacultyList&dept=Faculty&id=17800
Google:
"John Trojanowski"
Bio:

1998 AANP President

http://www.viswiki.com/en/John_Q._Trojanowski

http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=4

Cross-listing: Neurotree - Alzheimer's Tree

Parents

Sign in to add mentor
Nicholas K. Gonatas post-doc 1978-1980 Penn

Children

Sign in to add trainee
Lawrence C. Kenyon grad student 1993-1996 Penn (Neurotree)
Mark Stuart Forman post-doc Penn
Pallavi P. Gopal post-doc Penn (Neurotree)
Edward B. Lee post-doc Penn
Peter T. Nelson post-doc Penn
Daniel M. Skovronsky post-doc Penn
Stefan Prokop post-doc 2015- (Neurotree)
Raymond Scott Turner post-doc 1992-1995 Penn (Neurotree)
Kar-Ming Fung post-doc 1994-1995 University of Oklahoma Health Sciences Center
Ian Victor Joseph Murray post-doc 1999-2003 Indiana University of Pennsylvania (Neurotree)
Benoit I. Giasson post-doc 2001-2003 Penn (Neurotree)
Maria Martinez-Lage post-doc 2007-2008 Penn
Lionel Muller Igaz post-doc 2006-2010 Penn (Neurotree)
William T. Hu post-doc 2008-2010 University of Pennsylvania School of Medicine (Neurotree)
Corey T. McMillan research scientist 2013- Penn (Neurotree)
Kelly R Miller research scientist 2015-2016 Penn (Neurotree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kunkle BW, Grenier-Boley B, Sims R, et al. (2019) Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics
Deck BL, Xie SX, Choi G, et al. (2019) Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants. Movement Disorders Clinical Practice. 6: 440-445
Nho K, Kueider-Paisley A, Ahmad S, et al. (2019) Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. Jama Network Open. 2: e197978
Mollenhauer B, Caspell-Garcia CJ, Coffey CS, et al. (2019) Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society
Nelson PT, Dickson DW, Trojanowski JQ, et al. (2019) Reply: LATE to the PART-y. Brain : a Journal of Neurology
Prokop S, Miller KR, Labra SR, et al. (2019) Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples. Acta Neuropathologica
Henderson MX, Cornblath EJ, Darwich A, et al. (2019) Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nature Neuroscience. 22: 1248-1257
Giannini LAA, Xie SX, Peterson C, et al. (2019) Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration. Frontiers in Neuroscience. 13: 682
Cali CP, Patino M, Tai YK, et al. (2019) C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy. Acta Neuropathologica
Saito T, Mihira N, Matsuba Y, et al. (2019) Humanization of the entire murine gene provides a murine model of pathological human tau propagation. The Journal of Biological Chemistry
See more...